A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.

@article{Einvik2010ARC,
  title={A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.},
  author={Gunnar Einvik and Tor Ole Klemsdal and Leiv Sandvik and Elsa M. Hjerkinn},
  journal={European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology},
  year={2010},
  volume={17 5},
  pages={588-92}
}
BACKGROUND The benefit of n-3 polyunsaturated fatty acids (PUFA) supplementation for mortality and cardiovascular events after myocardial infarction is well documented, but the effect of n-3 PUFA in Caucasians without established cardiovascular disease is not known. Our aim was to examine the influence of supplementation with eicosapentaenoic acid and docosahexaenoic acid on all-cause mortality and cardiovascular events in elderly men at high-risk of cardiovascular disease. DESIGN In the Diet… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Omega 3 fatty acids in the elderly.

The British journal of nutrition • 2012
View 4 Excerpts
Highly Influenced

Triglycerides, Atherosclerosis, and Cardiovascular Outcome Studies: Focus on Omega-3 Fatty Acids.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…